Act Capital Management, LLC Atara Biotherapeutics, Inc. Transaction History
Act Capital Management, LLC
- $72.5 Million
- Q3 2022
A detailed history of Act Capital Management, LLC transactions in Atara Biotherapeutics, Inc. stock. As of the latest transaction made, Act Capital Management, LLC holds 900 shares of ATRA stock, worth $9,459. This represents 0.0% of its overall portfolio holdings.
Number of Shares
900
Previous 9,200
90.22%
Holding current value
$9,459
Previous $72,000
95.83%
% of portfolio
0.0%
Previous 0.1%
Shares
3 transactions
Others Institutions Holding ATRA
# of Institutions
7Shares Held
2.89MCall Options Held
0Put Options Held
0-
Kpcb Xv Associates, LLC1.88MShares$19.7 Million19.79% of portfolio
-
Antipodean Advisors LLC New York, NY1MShares$10.5 Million8.12% of portfolio
-
Ifp Advisors, Inc4.5KShares$47,2950.0% of portfolio
-
American Portfolios Advisors Holbrook, NY4.5KShares$47,2950.0% of portfolio
-
Wipfli Financial Advisors Llc,3.08KShares$32,3600.0% of portfolio
About Atara Biotherapeutics, Inc.
- Ticker ATRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,362,304
- Market Cap $992M
- Description
- Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...